Position in PCVX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$45,138,581
-$32,577,150 QoQ
Shares Held
776,511
-41.9% QoQ
Ownership
0.522%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#37
of 329 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,364,122 across 562 Biotechnology names. PCVX ranks #37 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in PCVX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,138,581 | 776,511 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $77,715,731 | 1,337,390 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $50,458,379 | 1,093,593 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $30,529,578 | 847,573 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $44,891,530 | 1,380,853 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $40,795,750 | 1,080,396 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $60,294,882 | 736,561 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $12,749,445 | 111,573 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,224,494 | 95,676 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,027,886 | 176,078 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $10,426,934 | 166,034 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,788,067 | 74,305 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $2,288,349 | 45,822 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $12,893 | 344 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,884,423 | 122,720 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,800 | 75 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $512,948 | 23,573 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,458,344 | 60,387 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,076,139 | 45,235 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,089,735 | 121,787 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,428,896 | 107,903 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,280,137 | 115,450 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,811,170 | 68,166 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $35,553 | 720 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||